Global RNAi Therapeutics In Depth Monitoring and Development Analysis

Global RNAi Therapeutics In-Depth Monitoring and Development Analysis Report 2023

Global RNAi Therapeutics In Depth Monitoring and Development Analysis

Global RNAi Therapeutics In-Depth Monitoring and Development Analysis Report 2023

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

The global RNAi Therapeutics market size in 2022 is 808.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 9.30% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:

The main players in the RNAi Therapeutics market include Quark Software Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Rexahn Pharmaceuticals, Inc. (U.S.), Silence Therapeutics (U.K.), and Arbutus Biopharma (U.S.). The share of the top 3 players in the RNAi Therapeutics market is XX%.

REGION SHARE:

The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of RNAi Therapeutics market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:

The report segments the market by Type and Application. Small Interfering RNAS accounted for XX% of RNAi Therapeutics market in 2022. Microrna share of XX%.

Intradermal Injections accounted for XX% of the RNAi Therapeutics market in 2022. Pulmonary Delivery accounts for XX%.

This RNAi Therapeutics market report provides detailed information on latest developments, trade regulations, value chain optimization, market share, impact of domestic and local market players, analyzes emerging revenue sources, market regulation changes Opportunities in Aspects, Strategic Market Growth Analysis, Market Size, Category Market Growth, Application Areas and Dominance, Product Approvals, Product Launches, Geographic Expansion, Technological Innovations in the Market.

RNAi Therapeutics market country level analysis

The countries covered in the RNAi Therapeutics market report include the United States, Canada, Germany, United Kingdom, France, Russia, Japan, China, India, South Korea, Brazil, UAE, Saudi Arabia, etc.

The presence and availability of global brands and challenges due to intense or scarce competition from local and domestic brands, and trade routes are also considered while providing the predictive analysis of country data.

Competitive Landscape and RNAi Therapeutics Market Share Analysis

RNAi Therapeutics market competitive landscape provides details by competitors. The detailed information includes company profile, company financials, revenue generated, market potential, R&D investments, new market plans, global reach. The data points presented above relate only to companies relevant to the RNAi Therapeutics market.

The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.

Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.

Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.

Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.

Highlights-Regions

North America

United States

Canada

Asia Pacific

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Nordic

South America

Brazil

Argentina

Colombia

Mexico

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

Player list

Quark Software Inc. (U.S.)

F. Hoffmann-La Roche Ltd. (Switzerland)

Rexahn Pharmaceuticals, Inc. (U.S.)

Silence Therapeutics (U.K.)

Arbutus Biopharma (U.S.)

Benitec Biopharma (Australia)

GSK plc (U.K.)

OLIX PHARMACEUTICALS, INC. (South Korea)

Sanofi (France)

Alnylam Pharmaceuticals, Inc. (U.S.)

Moderna Inc. (U.S.)

Ionis Pharmaceuticals (U.S.)

Types list

Small Interfering RNAS

Microrna

Application list

Intradermal Injections

Pulmonary Delivery

Intravenous Injections

Intraperitoneal Injections

Others

Table of Content

1 RNAi Therapeutics Market Introduction and Overview

1.1 RNAi Therapeutics Definition

1.2 Market Size Analysis by Types

1.3 Market Size Analysis by Application

1.4 Research Purposes

1.5 Report Timeline

1.6 Economic Analysis of Global Regions

2 Global Market Growth Trends Analysis

2.1 Global RNAi Therapeutics Market Size & Forecast (2018-2029)

2.2 RNAi Therapeutics Growth Trends Analysis by Regions

2.2.1 RNAi Therapeutics Market Size by Regions: 2018 VS 2023 VS 2029

2.2.2 RNAi Therapeutics Historic Market Size by Regions (2018-2023)

2.2.3 RNAi Therapeutics Forecasted Market Size by Regions (2023-2029)

2.2.4 North America RNAi Therapeutics Market Size & Forecast (2018-2029)

2.2.5 Europe RNAi Therapeutics Market Size & Forecast (2018-2029)

2.2.6 Asia-Pacific RNAi Therapeutics Market Size & Forecast (2018-2029)

2.2.7 Latin America RNAi Therapeutics Market Size & Forecast (2018-2029)

2.2.8 Middle East & Africa RNAi Therapeutics Market Size & Forecast (2018-2029)

3 North America

3.1 North America RNAi Therapeutics Revenue by Countries

3.1.1 North America RNAi Therapeutics Revenue by Countries (2018-2029)

3.2 North America RNAi Therapeutics Revenue by Players

3.3 North America RNAi Therapeutics Revenue by Types

3.4 North America RNAi Therapeutics Revenue by Applications

3.5 United States

3.6 Canada

4 Asia Pacific

4.1 Asia Pacific RNAi Therapeutics Revenue by Countries

4.1.1 Asia Pacific RNAi Therapeutics Revenue by Countries (2018-2029)

4.2 Asia Pacific RNAi Therapeutics Revenue by Players

4.3 Asia Pacific RNAi Therapeutics Revenue by Types

4.4 Asia Pacific RNAi Therapeutics Revenue by Applications

4.5 China

4.6 Japan

4.7 Korea

4.8 Southeast Asia

4.9 India

4.10 Australia

5 Europe

5.1 Europe RNAi Therapeutics Revenue by Countries

5.1.1 Europe RNAi Therapeutics Revenue by Countries (2018-2029)

5.2 Europe RNAi Therapeutics Revenue by Players

5.3 Europe RNAi Therapeutics Revenue by Types

5.4 Europe RNAi Therapeutics Revenue by Applications

5.5 Germany

5.6 France

5.7 UK

5.8 Italy

5.9 Russia

5.10 Spain

5.11 Nordic

6 Latin America

6.1 Latin America RNAi Therapeutics Revenue by Countries

6.1.1 Latin America RNAi Therapeutics Revenue by Countries (2018-2029)

6.2 Latin America RNAi Therapeutics Revenue by Players

6.3 Latin America RNAi Therapeutics Revenue by Types

6.4 Latin America RNAi Therapeutics Revenue by Applications

6.5 Brazil

6.6 Argentina

6.7 Colombia

6.8 Mexico

7 Middle East & Africa

7.1 Middle East & Africa RNAi Therapeutics Revenue by Countries

7.1.1 Middle East & Africa RNAi Therapeutics Revenue by Countries (2018-2029)

7.2 Middle East & Africa RNAi Therapeutics Revenue by Players

7.3 Middle East & Africa RNAi Therapeutics Revenue by Types

7.4 Middle East & Africa RNAi Therapeutics Revenue by Applications

7.5 Egypt

7.6 South Africa

7.7 Israel

7.8 Turkey

7.9 GCC Countries

8 Global RNAi Therapeutics Historical and Forecast Market Analysis by Type

8.1 Global RNAi Therapeutics Revenue and Market Share by Type

8.2 Global RNAi Therapeutics Market Forecast by Type (2023-2029)

9 Global RNAi Therapeutics Historical and Forecast Market Analysis by Application

9.1 Global RNAi Therapeutics Revenue Market Share by Application (2018-2023)

9.2 RNAi Therapeutics Market Forecast by Application (2023-2029)

10 RNAi Therapeutics Industry Dynamic Analysis

10.1 RNAi Therapeutics Market Trends Analysis

10.2 RNAi Therapeutics Market Drivers Analysis

10.3 RNAi Therapeutics Market Challenges Analysis

10.4 RNAi Therapeutics Market Restraints Analysis

10.5 RNAi Therapeutics Industry Mergers & Acquisitions

10.6 RNAi Therapeutics Industry New Entrants and Expansion Plans

11 Players Profiles

11.1 Quark Software Inc. (U.S.)

11.1.1 Quark Software Inc. (U.S.) Company Profile

11.1.2 RNAi Therapeutics Product Overview

11.1.3 Quark Software Inc. (U.S.) RNAi Therapeutics Market Performance (2018-2023)

11.1.4 Quark Software Inc. (U.S.) Business Overview

11.2 F. Hoffmann-La Roche Ltd. (Switzerland)

11.2.1 F. Hoffmann-La Roche Ltd. (Switzerland) Company Profile

11.2.2 RNAi Therapeutics Product Overview

11.2.3 F. Hoffmann-La Roche Ltd. (Switzerland) RNAi Therapeutics Market Performance (2018-2023)

11.2.4 F. Hoffmann-La Roche Ltd. (Switzerland) Business Overview

11.3 Rexahn Pharmaceuticals, Inc. (U.S.)

11.3.1 Rexahn Pharmaceuticals, Inc. (U.S.) Company Profile

11.3.2 RNAi Therapeutics Product Overview

11.3.3 Rexahn Pharmaceuticals, Inc. (U.S.) RNAi Therapeutics Market Performance (2018-2023)

11.3.4 Rexahn Pharmaceuticals, Inc. (U.S.) Business Overview

11.4 Silence Therapeutics (U.K.)

11.4.1 Silence Therapeutics (U.K.) Company Profile

11.4.2 RNAi Therapeutics Product Overview

11.4.3 Silence Therapeutics (U.K.) RNAi Therapeutics Market Performance (2018-2023)

11.4.4 Silence Therapeutics (U.K.) Business Overview

11.5 Arbutus Biopharma (U.S.)

11.5.1 Arbutus Biopharma (U.S.) Company Profile

11.5.2 RNAi Therapeutics Product Overview

11.5.3 Arbutus Biopharma (U.S.) RNAi Therapeutics Market Performance (2018-2023)

11.5.4 Arbutus Biopharma (U.S.) Business Overview

11.6 Benitec Biopharma (Australia)

11.6.1 Benitec Biopharma (Australia) Company Profile

11.6.2 RNAi Therapeutics Product Overview

11.6.3 Benitec Biopharma (Australia) RNAi Therapeutics Market Performance (2018-2023)

11.6.4 Benitec Biopharma (Australia) Business Overview

11.7 GSK plc (U.K.)

11.7.1 GSK plc (U.K.) Company Profile

11.7.2 RNAi Therapeutics Product Overview

11.7.3 GSK plc (U.K.) RNAi Therapeutics Market Performance (2018-2023)

11.7.4 GSK plc (U.K.) Business Overview

11.8 OLIX PHARMACEUTICALS, INC. (South Korea)

11.8.1 OLIX PHARMACEUTICALS, INC. (South Korea) Company Profile

11.8.2 RNAi Therapeutics Product Overview

11.8.3 OLIX PHARMACEUTICALS, INC. (South Korea) RNAi Therapeutics Market Performance (2018-2023)

11.8.4 OLIX PHARMACEUTICALS, INC. (South Korea) Business Overview

11.9 Sanofi (France)

11.9.1 Sanofi (France) Company Profile

11.9.2 RNAi Therapeutics Product Overview

11.9.3 Sanofi (France) RNAi Therapeutics Market Performance (2018-2023)

11.9.4 Sanofi (France) Business Overview

11.10 Alnylam Pharmaceuticals, Inc. (U.S.)

11.10.1 Alnylam Pharmaceuticals, Inc. (U.S.) Company Profile

11.10.2 RNAi Therapeutics Product Overview

11.10.3 Alnylam Pharmaceuticals, Inc. (U.S.) RNAi Therapeutics Market Performance (2018-2023)

11.10.4 Alnylam Pharmaceuticals, Inc. (U.S.) Business Overview

11.11 Moderna Inc. (U.S.)

11.11.1 Moderna Inc. (U.S.) Company Profile

11.11.2 RNAi Therapeutics Product Overview

11.11.3 Moderna Inc. (U.S.) RNAi Therapeutics Market Performance (2018-2023)

11.11.4 Moderna Inc. (U.S.) Business Overview

11.12 Ionis Pharmaceuticals (U.S.)

11.12.1 Ionis Pharmaceuticals (U.S.) Company Profile

11.12.2 RNAi Therapeutics Product Overview

11.12.3 Ionis Pharmaceuticals (U.S.) RNAi Therapeutics Market Performance (2018-2023)

11.12.4 Ionis Pharmaceuticals (U.S.) Business Overview

12 Research Findings and Conclusion

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Global RNAi Therapeutics In Depth Monitoring and Development Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
What trends are influencing the growth of the Global RNAi Therapeutics In Depth Monitoring and Development Market?
New players are entering the Global RNAi Therapeutics In Depth Monitoring and Development Market, while established companies are changing their business models and strategies. This pattern is likely to continue for the foreseeable future.
What are the major applications for Global RNAi Therapeutics In Depth Monitoring and Development?
Global RNAi Therapeutics In Depth Monitoring and Development has a wide range of applications, including and others.
What is the estimated size & growth rate of the Global RNAi Therapeutics In Depth Monitoring and Development Market?
In recent years, the Global RNAi Therapeutics In Depth Monitoring and Development Market has grown at an incredible rate. From 2025 to 2030, the market is expected to grow at a CAGR of yy%.
In the current situation, what value does the Global RNAi Therapeutics In Depth Monitoring and Development Market have?
The value of the Global RNAi Therapeutics In Depth Monitoring and Development Market is estimated to be USD XXX million.
Who should consider the Global RNAi Therapeutics In Depth Monitoring and Development Market study?
The Global RNAi Therapeutics In Depth Monitoring and Development Industry stakeholders, executives, and experts, as well as individuals who need to develop consumer-friendly strategies and use technology to stay ahead of the competition.